ConductScience.org, home

Paper36964440

Sustained antigens delivery using composite microneedles for effective epicutaneous immunotherapy.

Zhang E and 4 others. Drug Deliv Transl Res, 2023. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Sustained antigens delivery using composite microneedles for effective epicutaneous immunotherapy. Papers, record 36964440. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36964440

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sustained antigens delivery using composite microneedles for effective epicutaneous immunotherapy.
PubMed
Journal
Drug Deliv Transl Res
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
1.48
iCite
Revised in PubMed
2026-10-30
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zhang EErkang
2Zeng BBinghui
3Song RRuolin
4Yao LLu
5Che HHuilian

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SkinMajor topic
VaccinesMajor topic
Mice
Animals
Immunotherapy
Silk
Needles
Drug Delivery Systems
Administration, Cutaneous

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in38720164Correction: Sustained antigens delivery using composite microneedles for effective epicutaneous immunotherapy.https://conductscience.org/library/papers/38720164

Source PubMed

Download CSV of comments and corrections

References59

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124636471State of the art on food allergen immunotherapy: oral, sublingual, and epicutaneous.J Allergy Clin Immunol2014https://conductscience.org/library/papers/24636471PubMed
217643485Silk fibroin matrices for the controlled release of nerve growth factor (NGF).Biomaterials2007https://conductscience.org/library/papers/17643485PubMed
321959241Materials fabrication from Bombyx mori silk fibroin.Nat Protoc2011https://conductscience.org/library/papers/21959241PubMed
420934206Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study.J Allergy Clin Immunol2010https://conductscience.org/library/papers/20934206PubMed
523369214Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination.Biomaterials2013https://conductscience.org/library/papers/23369214PubMed
627795547Food allergy: immune mechanisms, diagnosis and immunotherapy.Nat Rev Immunol2016https://conductscience.org/library/papers/27795547PubMed
726437262IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery.J Control Release2015https://conductscience.org/library/papers/26437262PubMed
829081025The Current State of Epicutaneous Immunotherapy for Food Allergy: a Comprehensive Review.Clin Rev Allergy Immunol2018https://conductscience.org/library/papers/29081025PubMed
916998509Immunological mechanisms of allergen-specific immunotherapy.Nat Rev Immunol2006https://conductscience.org/library/papers/16998509PubMed
1021481024Oral desensitization as a useful treatment in 2-year-old children with cow's milk allergy.Clin Exp Allergy2011https://conductscience.org/library/papers/21481024PubMed
1133340568Microneedles for painless transdermal immunotherapeutic applications.J Control Release2021https://conductscience.org/library/papers/33340568PubMed
1231626861Microneedles coated with peanut allergen enable desensitization of peanut sensitized mice.J Control Release2019https://conductscience.org/library/papers/31626861PubMed
1334087444Epigallocatechin gallate/L-ascorbic acid-loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis.Acta Biomater2021https://conductscience.org/library/papers/34087444PubMed
1423181380Sialoadhesin - a macrophage-restricted marker of immunoregulation and inflammation.Immunology2013https://conductscience.org/library/papers/23181380PubMed
1529909233Phenotype analyses of IL-10-producing Foxp3- CD4+ T cells increased by subcutaneous immunotherapy in allergic airway inflammation.Int Immunopharmacol2018https://conductscience.org/library/papers/29909233PubMed
1620460624Diagnosing and managing common food allergies: a systematic review.JAMA2010https://conductscience.org/library/papers/20460624PubMed
1725243789Dissolving microneedle delivery of nanoparticle-encapsulated antigen elicits efficient cross-priming and Th1 immune responses by murine Langerhans cells.J Invest Dermatol2015https://conductscience.org/library/papers/25243789PubMed
1820732409Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss.Toxicol In Vitro2010https://conductscience.org/library/papers/20732409PubMed
1916675328Sublingual immunotherapy: a comprehensive review.J Allergy Clin Immunol2006https://conductscience.org/library/papers/16675328PubMed
2023137786Silk fibroin biomaterials for tissue regenerations.Adv Drug Deliv Rev2013https://conductscience.org/library/papers/23137786PubMed

See all 59 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42895906Microneedle-based drug delivery for inflammatory and immune-mediated ocular diseases: current applications and future perspectives.Drug Deliv2026https://conductscience.org/library/papers/42895906PubMed
41108464Microneedles in Allergy Immunotherapy: the Present and Future.Curr Allergy Asthma Rep2025https://conductscience.org/library/papers/41108464PubMed
40860158Co-delivery of targeted hypoallergens and resiquimod powders using silk fibroin microneedles for effective allergen-specific immunotherapy.Theranostics2025https://conductscience.org/library/papers/40860158PubMed
39394201Synthesis of vitamin D3 loaded ethosomes gel to cure chronic immune-mediated inflammatory skin disease: physical characterization, in vitro and ex vivo studies.Sci Rep2024https://conductscience.org/library/papers/39394201PubMed
38956885Advances in polymeric nano-delivery systems targeting hair follicles for the treatment of acne.Drug Deliv2024https://conductscience.org/library/papers/38956885PubMed
38670230Advancing immunotherapy using biomaterials to control tissue, cellular, and molecular level immune signaling in skin.Adv Drug Deliv Rev2024https://conductscience.org/library/papers/38670230PubMed
38260178Allergen immunotherapy in China.Front Allergy2023https://conductscience.org/library/papers/38260178PubMed
38170619Therapeutic synthetic and natural materials for immunoengineering.Chem Soc Rev2024https://conductscience.org/library/papers/38170619PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36964440

GET https://conductscience.org/api/papers/v1/36964440/references?page=2